A new House bill would amend the Food, Drug, and Cosmetic Act to grant FDA more authority against products that don't meet the definition of dietary supplement.
Givaudan’s ThinkBlue was found to support cognitive function greater than placebo in two separate studies involving a total of 72 healthy older adults.